Bontac Bio-engineering (Shenzhen) Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bontac Bio-engineering (Shenzhen) Co., Ltd. - overview
Established
2012
Location
Shenzhen, Guangdong, China
Primary Industry
Biotechnology
About
Established in 2012 and based in Shenzhen, China, Bontac Bio-engineering (Shenzhen) Co. , Ltd. is a biotech company that focuses on the research and development of coenzyme series pharmaceutical intermediates and raw materials. In 2014, the company established a full enzyme catalytic coenzyme production line.
In March 2017, the firm closed a series B funding. As of September 2024, it has applied for more than 180 domestic and foreign patents, including more than 170 invention patents. The company's main products include coenzyme series, natural product series, sugar substitute series, etc. It also provides OEM customization services for cosmetics and health products.
The company's products are used in nutrition and health, biomedicine, medical beauty and other fields. The company’s revenue is generated by providing coenzyme series pharmaceutical intermediates and raw materials.
Current Investors
Fang Fund Partners, Sangel Capital, SZ Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.bontac-bio.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.